Zika vaccine research continues in the absence of a large-scale outbreak, but a shortage of cases is making it hard to test for efficacy.

Merck is already in phase 3 testing for its next-generation pneumococcal vaccine, and Pfizer's CFO said his company is "all in" on advancing its…

Without additional funding, the world won't see new "highly efficacious" vaccines against HIV, tuberculosis and malaria, according to a new…

No production or safety problems were found at the other 45 vaccine manufacturers in China, the country's drug regulator says.

Sun brings experience from the FDA, CDC and Walter Reed Army Institute of Research to his role at the biotech unicorn.

Here is some other vaccine news of note for the week.

A group of pediatric experts has recommended injected vaccines over AstraZeneca's FluMist for the upcoming season.

In what a WHO official described as "high community demand," 4,625 doses of Merck's Ebola vaccine, rVSV-ZEBOV, have been given in the latest…